Showing results (1-10 of 197) with videos related to
Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|November 18, 2014
Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continuesN K Gillis, F InnocentiEuropean Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Update on pharmacogenetics in cancer chemotherapyF Innocenti, M J RatainMinerva Cardioangiologica|July 11, 2002
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertensionV Palmieri, R B DevereuxJournal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Diastolic dysfunction in arterial hypertensionG de Simone, V PalmieriJournal of Pharmaceutical Sciences|May 1, 1980
Thermal decomposition of ibuproxamS Chimichi, F Innocenti, G OrzalesiClinical Pharmacokinetics|December 7, 2000
Pharmacogenetics: a tool for individualizing antineoplastic therapyF Innocenti, L Iyer, M J RatainAnnual Review of Medicine|January 15, 2003
Pharmacogenetics in cancer treatmentR Nagasubramanian, F Innocenti, M J RatainDrug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecanF Innocenti, L Iyer, M J RatainCritical Reviews in Oncology/Hematology|June 13, 2018
"No pain, No gain" still true with immunotherapy: When the finger shows the moon, look at the moon!G Milano, F Innocenti, B Lacarelle, et al.Pageof 20